atomoxetine hydrochloride has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, WH; Beglinger, LJ; Duff, K; Fiedorowicz, JG; Langbehn, DR; Leserman, A; Paulsen, JS; Paulson, H | 1 |
1 trial(s) available for atomoxetine hydrochloride and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Randomized controlled trial of atomoxetine for cognitive dysfunction in early Huntington disease.
Topics: Adult; Atomoxetine Hydrochloride; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Female; Humans; Huntington Disease; Male; Middle Aged; Pilot Projects; Propylamines; Time Factors; Young Adult | 2009 |